Evidence map›Paper›PMID 40491692›Full record

ArticleJournal of diabetes and metabolic disorders2025

Pattern of salt intake among Iranian hypertensive patients: insights from the 2021 STEPS study.

Amirhossein Ghaseminejad-Raeini, Keyvan Karimi, Nazila Rezaei, Yosra Azizpour, Moloud Payab, Mojtaba Lotfaliany, Mina Mirzad, Ali Golestani, Soroush Mozafari, Mahnaz Pejman Sani and 1 more

Abstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Amirhossein Ghaseminejad-Raeini *Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Keyvan Karimi *Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Nazila RezaeiNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Yosra AzizpourNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Moloud PayabNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mojtaba LotfalianyDeakin University, the Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Barwon Health, Geelong, VIC Australia.
Mina MirzadNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ali GolestaniNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Soroush MozafariNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mahnaz Pejman SaniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Samaneh AkbarpourNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Excessive salt intake is a global health concern, particularly for individuals with hypertension (HTN). Limited research has examined the relationship between salt consumption and blood pressure control in Iranians. This study aimed to evaluate daily salt intake among hypertensive Iranians and its association with blood pressure management. Methods: Data were obtained from Iran's 2021 STEPS survey. Sample hypertensive patients were defined by self-report, antihypertensive medication use, or blood pressure (BP) measurements (SBP ≥ 140 mmHg or DBP ≥ 90 mmHg). Daily salt intake was estimated using the Tanaka method based on spot urine sodium levels and categorized based on calculated quartiles. BP was analyzed in both continuous and binary forms (controlled/uncontrolled). Logistic regression was applied to assess relationship between daily salt intake and uncontrolled hypertension as outcome. Results: The final analysis included 6,795 participants who were divided into four quartiles according to their daily salt intake. With a mean daily salt intake of 10.1 g [95% Confidence Interval (CI): 9.9-10.3], participants with undiagnosed hypertension consumed the most salt, (10.1 g [95% CI: 9.9-10.3], Conclusions: Since increased salt intake raises SBP and DBP, particularly in those who are unaware of their condition, this study emphasizes the urgent need for public health interventions, such as nutritional counselling for low-salt diet, to reduce salt intake, especially in the Iranian population suffering from hypertension.

Indexed as

Diastolic blood pressureIranSalt intakeSurveySystolic blood pressure

Identifiers

PMID40491692
PMCPMC12145363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.